|
gptkbp:instance_of
|
gptkb:Ophthalmology
|
|
gptkbp:administered_by
|
ear drops
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:availability
|
prescription required
|
|
gptkbp:available_in
|
multiple strengths
|
|
gptkbp:class
|
gptkb:pharmaceuticals
gptkb:Android
|
|
gptkbp:clinical_trial
|
Phase III
|
|
gptkbp:clinical_use
|
post-operative care
ear surgery
|
|
gptkbp:contains
|
gptkb:ciprofloxacin
gptkb:dexamethasone
|
|
gptkbp:contraindication
|
fungal infections
viral infections
patients with a known allergy to ciprofloxacin
patients with a known allergy to dexamethasone
|
|
gptkbp:dosage_form
|
gptkb:liquid
|
|
gptkbp:duration_of_treatment
|
7 days
|
|
gptkbp:formulation
|
suspension
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ciprodex
|
|
gptkbp:indication
|
acute otitis externa
otitis media with effusion
|
|
gptkbp:ingredients
|
gptkb:ciprofloxacin_hydrochloride
gptkb:dexamethasone_sodium_phosphate
|
|
gptkbp:interacts_with
|
other otic medications
systemic corticosteroids
|
|
gptkbp:manufacturer
|
gptkb:Alcon
|
|
gptkbp:marketed_as
|
gptkb:brand
|
|
gptkbp:mechanism_of_action
|
reduces inflammation
inhibits bacterial DNA synthesis
|
|
gptkbp:packaging
|
gptkb:bottle
|
|
gptkbp:patient_population
|
gptkb:children
adults
|
|
gptkbp:previous_name
|
gptkb:ciprofloxacin/dexamethasone
|
|
gptkbp:price
|
varies by pharmacy
|
|
gptkbp:provides_guidance_on
|
gptkb:Infectious_Diseases_Society_of_America
gptkb:American_Academy_of_Otolaryngology
|
|
gptkbp:requires
|
prescription only
|
|
gptkbp:route_of_administration
|
topical
|
|
gptkbp:service_frequency
|
twice daily
|
|
gptkbp:shelf_life
|
3 years
|
|
gptkbp:side_effect
|
nausea
swelling
vomiting
diarrhea
itching
ear discomfort
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:used_for
|
treating ear infections
|
|
gptkbp:bfsParent
|
gptkb:Valeant_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
6
|